NCT00284973View on ClinicalTrials.gov

A Study of Safety and Immunogenicity of a Malaria Vaccine Candidate

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2006

Conditions
Prophylaxis Against Plasmodium Falciparum Malaria
Interventions
BIOLOGICAL

Plasmodium falciparum Chimeric Prot. 2.9 - Montanide ISA 720

Trial Locations (1)

Unknown

Shanghai Changhai Hospital, Shanghai

All Listed Sponsors
collaborator

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

Second Military Medical University

OTHER

collaborator

World Health Organization

OTHER

collaborator

PATH

OTHER

lead

Shanghai Wanxing Bio-Pharmaceutical Co. Ltd.

INDUSTRY

NCT00284973 - A Study of Safety and Immunogenicity of a Malaria Vaccine Candidate | Biotech Hunter | Biotech Hunter